₹-5.50
(Market cap
₹313 Cr
Recently Viewed
Clear AllMarket cap
₹313 Cr
Revenue (TTM)
₹128 Cr
P/E Ratio
--
P/B Ratio
62.6
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹-24 Cr
ROE
-86.4 %
ROCE
-8.9 %
Industry P/E
55.58
EV/EBITDA
-50
Debt to Equity
20.2
Book Value
₹3.8
EPS
₹-20.2
Face value
10
Shares outstanding
12,995,085
CFO
₹40.93 Cr
EBITDA
₹49.41 Cr
Net Profit
₹-2.23 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Kerala Ayurveda
| -23.8 | 30.2 | -14.6 | -27.0 | 35.5 | 36.7 | 15.8 |
|
BSE Healthcare
| 0.0 | 2.7 | 4.4 | 4.2 | 24.0 | 13.2 | 10.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Kerala Ayurveda
| -28.1 | 65.1 | 152.1 | 55.5 | 38.2 | 14.5 | -43.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Kerala Ayurveda
|
240.5 | 312.5 | 127.7 | -24.3 | -20.8 | -325.5 | -- | 62.6 |
| 2,791.2 | 34,930.8 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 5.0 | 6.0 | 0.5 | -0.1 | -89.9 | -- | -- | 0.5 | |
| 24.6 | 14.0 | 8.0 | 0.6 | 13.8 | 5.5 | 22.2 | 1.1 | |
| 1,592.7 | 30,187.4 | 8,850.1 | 894.8 | 15.2 | 19.8 | 34.7 | 6.1 | |
| 11.1 | 3.8 | 2.4 | 0.1 | -2.4 | -- | 37.6 | -9.1 | |
| 1,992.9 | 31,997.7 | 4,193.0 | 753.8 | 22.7 | 20.8 | 42.4 | 8.0 | |
| 24.8 | 42.5 | 49.3 | 0.8 | 1.6 | 4.5 | 55.9 | 2.5 | |
| 38.1 | 36.8 | 67.2 | 2.1 | 3.3 | 4.9 | 18 | 1.1 | |
| 130.2 | 83.8 | 65.4 | 2.8 | 6.6 | 12.1 | 30.1 | 3.4 |
No Review & Analysis are available.
Kerala Ayurveda Limited manufactures and sells ayurvedic products in India. The company offers 350 classical and proprietary ayurvedic medicines, including therapeutic formulations, as well as health supplements, skin and beauty care products, and... specialty foods. Its products include child/kids health, diabetes, heart health, eye care, gastro care, joint care, lifestyle, massage oils, men and women care, renal, respiratory and allergy, skin and hair care, general health/immunity, arishtam, thailam, gulika/pills/tab, kwath, gritham, kuzhambu, keram, asavam, avarthanams, choornam, lehyam, rasayanam, ayurveda soaps, and organic superfood products. It also provides wellness centers and clinics, hospitals, health village, wellness resort, and yoga therapy services, as well as academies. The company also exports its products. The company was founded in 1945 and is based in Bengaluru, India. Kerala Ayurveda Limited is a subsidiary of Katra Holdings Ltd. Read more
Incorporated
1992
Chairman
Ramesh Vangal
Managing Director
--
Group
Kerala Ayurveda - MNC
Headquarters
Ernakulam, Kerala
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsAnnouncement Under Regulation 30 (LODR)
16-Apr-2026Clarification On Price Movement
08-Apr-2026Clarification sought from Kerala Ayurveda Ltd
08-Apr-2026No News & Announcements are available.
The share price of Kerala Ayurveda Ltd is ₹240.50 (BSE) as of 21-Apr-2026 IST. Kerala Ayurveda Ltd has given a return of 35.54% in the last 3 years.
Since, TTM earnings of Kerala Ayurveda Ltd is negative, P/E ratio is not available.
The P/B ratio of Kerala Ayurveda Ltd is 62.60 times as on 21-Apr-2026, a 86 premium to its peers’ median range of 33.66 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
129.43
|
|
2024
|
0.00
|
10.83
|
|
2023
|
0.00
|
32.49
|
|
2022
|
34.93
|
26.68
|
|
2021
|
0.00
|
140.57
|
The 52-week high and low of Kerala Ayurveda Ltd are Rs 625.00 and Rs 150.00 as of 21-Apr-2026.
Kerala Ayurveda Ltd has a market capitalisation of ₹ 313 Cr as on 21-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Kerala Ayurveda Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.